Ушбу ишга иқтибос қилган ишлар

11 та иш

Иш: Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

1. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Шарҳ мақолаTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 иқтибос

   ABIABI:AkademIndex/openalex/2017.review-article.000004

2. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   James M. Trauer, Jay Achar, Nargiza Parpieva +7

   МақолаTuberculosis Research and EpidemiologyBMC Medicine20163 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.195695

3. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

   Khasan Safaev, Nargiza Parpieva, Irina Liverko +5

   МақолаTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.000207

4. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

   МақолаTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20181 иқтибос

   ABIABI:AkademIndex/openalex/2018.article.000181

5. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   МақолаTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 иқтибос

   ABIABI:AkademIndex/openalex/2019.article.000020

6. Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis

   Aleksandr Trubnikov, Arax Hovhannesyan, Kristina Akopyan +5

   МақолаTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.262608

7. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

   Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

   МақолаTuberculosis Research and EpidemiologyERJ Open Research20201 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.360284

8. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Shona Horter, Jay Achar, Nell Gray +4

   МақолаTuberculosis Research and EpidemiologyPLoS ONE20201 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.360285

9. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study

   M. Bonnet, Mathieu Bastard, Philipp du Cros +9

   МақолаTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20150 иқтибос

   ABIABI:AkademIndex/openalex/2015.article.000040

10. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen

    Jay Achar, Catherine Berry, Krzysztof Herboczek +7

    БошқаTuberculosis Research and EpidemiologyEmerging infectious diseases20150 иқтибос

    ABIABI:AkademIndex/openalex/2015.other.000001

11. Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan

    Horacio Gil, Hasmik Margaryan, I. Azamat +8

    МақолаTuberculosis Research and EpidemiologyTropical Medicine & International Health20210 иқтибос

    ABIABI:AkademIndex/openalex/2021.article.003743